Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial.
Shitara K, Di Bartolomeo M, Mandala M, Ryu MH, Caglevic C, Olesinski T, Chung HC, Muro K, Goekkurt E, McDermott RS, Mansoor W, Wainberg ZA, Shih CS, Kobie J, Nebozhyn M, Cristescu R, Cao ZA, Loboda A, Özgüroğlu M.
Shitara K, et al. Among authors: goekkurt e.
J Immunother Cancer. 2023 Jun;11(6):e006920. doi: 10.1136/jitc-2023-006920.
J Immunother Cancer. 2023.
PMID: 37399357
Free PMC article.
Clinical Trial.